newsDespite some challenges, for the Alzheimer’s drug development pipeline, 2024…
25 April 2024 | By Catherine Eckford (European Pharmaceutical Review)
Despite some challenges, for the Alzheimer’s drug development pipeline, 2024 is a “learning year”, an expert on the disease says.